IGC vs BIIB: Which Stock is Better?
Side-by-side comparison of Igc Pharma Inc and Biogen Inc in 2026
IGC
Igc Pharma Inc
$0.31
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IGC | BIIB | Winner |
|---|---|---|---|
| Market Cap | $30.64M | $26.26B | BIIB |
| P/E Ratio | N/A | 20.38 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -0.5% | -0.1% | BIIB |
| Gross Margin | 46.2% | 78.9% | BIIB |
Analyze IGC
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IGC or BIIB a better investment?
Comparing IGC and BIIB: Igc Pharma Inc has a market cap of $30.64M while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IGC and BIIB?
IGC (Igc Pharma Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IGC or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IGC or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.5% for IGC.
Which company is more profitable: IGC or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 46.2% for IGC.
Which is the larger company: IGC or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $30.64M for IGC.
Should I buy IGC or BIIB in 2026?
Both IGC and BIIB have investment merit. IGC trades at $0.31 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IGC and BIIB stock?
Key differences: Market Cap ($30.64M vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.5% vs -0.1%), Gross Margin (46.2% vs 78.9%).